Walleye Capital
HCAT icon

Walleye Capital’s Health Catalyst HCAT Stock Holding History

Walleye Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,910
Closed -$35.6K – 4640
2025
Q4 		$35.6K Sell
14,910
-611
-4% -$1.67K ﹤0.01% 4155
2025
Q3 		$44.2K Buy
+15,521
New +$53.1K ﹤0.01% 4042
2024
Q4 		– Sell
-38,829
Closed -$316K – 5124
2024
Q3 		$316K Sell
38,829
-6,655
-15% -$48.1K ﹤0.01% 3692
2024
Q2 		$291K Sell
45,484
-15,600
-26% -$100K ﹤0.01% 4004
2024
Q1 		$460K Buy
+61,084
New +$558K ﹤0.01% 3268
2023
Q2 		– Sell
-16,218
Closed -$189K – 4530
2023
Q1 		$189K Sell
16,218
-86,451
-84% -$1.1M ﹤0.01% 2512
2022
Q4 		$1.09M Sell
102,669
-221,298
-68% -$2.14M 0.02% 947
2022
Q3 		$3.14M Buy
323,967
+311,466
+2,492% +$4.12M 0.06% 353
2022
Q2 		$181K Buy
+12,501
New +$213K 0.01% 1561
2021
Q4 		– Sell
-5,388
Closed -$269 – 2189
2021
Q3 		$269 Sell
5,388
-11,861
-69% -$647K 0.01% 1066
2021
Q2 		$957 Buy
+17,249
New +$919K 0.03% 466
2021
Q1 		– Sell
-7,500
Closed -$326 – 1242
2020
Q4 		$326 Buy
+7,500
New +$277K 0.02% 602

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's HCAT Position: Q1 2026 in Review

Walleye Capital sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 14,910 shares — an estimated $35.6K sold.

Walleye Capital first reported a position in HCAT in Q4 2020 and held it in 12 quarters. The position peaked at $3.14M in Q3 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Walleye Capital reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 14,910 Health Catalyst shares in Q1 2026, an estimated $35.6K.
  • Walleye Capital first reported a position in Health Catalyst in Q4 2020 and held it in 12 quarters.
  • Walleye Capital's Health Catalyst position peaked at $3.14M in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.